Previous | Home | EndoTODAY | List | Next


[Q&A] Esophagus other than GERD

Plummer Vinson syndrome

[¾Öµ¶ÀÚ Áú¹®] Æò¼Ò ¾à°£ dysphagia°¡ ÀÖ´ø ºÐÀÔ´Ï´Ù. Pyriform fossa¿¡ µé¾î°¡ÀÚ ¸¶ÀÚ esophageal web ÀǽɵǴ º´º¯ÀÌ ÀÖ¾ú½À´Ï´Ù. µé¾î°¥ ¼ö ÀÖÀ»±î Àá½Ã °í¹ÎÇÏ´Ù°¡ ¾à°£ÀÇ ÀúÇ×À» ´À³¢¸é¼­ ¾ÈÀ¸·Î ÁøÀÔÇÏ¿´½À´Ï´Ù. ¾î¶»°Ô »ý°¢ÇϽôÂÁö¿ä.

[ÀÌÁØÇàÀÇ ´äº¯] ½Äµµ webÀÔ´Ï´Ù. Plummer Vinson ÁõÈıºÀÏ ¼ö ÀÖÀ¸´Ï hemoglobinÀ» °Ë»çÇϽðí glossitis°¡ ¾ø´ÂÁö º¸¼¼¿ä. °£È¤ GERD ȯÀÚ°¡ »óºÎ½ÄµµÀÇ webÀ» Çü¼ºÇÏ´Â ¼öµµ ÀÖ½À´Ï´Ù. »ê¿ª·ù Áõ»óÀº ¾ø´ÂÁö ¹°¾îº¸¼¼¿ä.

[¾Öµ¶ÀÚÀÇ Ãß°¡ ÀÇ°ß] °¨»çÇÕ´Ï´Ù. ȯÀÚºÐÀº Plummer Vinson syndromeÀÌ ¸Â´Â °Í °°½À´Ï´Ù.^^ HemoglobinÀº 7 Á¤µµÀ̸ç, angular stomatitisµµ ÀÖ°í tongue mucosaµµ ¾à°£ ÀÌ»óÇØ º¸¿´½À´Ï´Ù. Àú´Â óÀ½ °æÇèÇÑ »ç·ÊÀÔ´Ï´Ù.

[ÀÌÁØÇàÀÇ Ãß°¡ ´äº¯] Àúµµ µ¿ÀÇÇÕ´Ï´Ù. Plummer Vinson ÁõÈıºÀÌ ¸Â´Ù°í »ý°¢ÇÕ´Ï´Ù. °ú°Å »ç·Ê Çϳª¸¦ ¼Ò°³ÇÕ´Ï´Ù.

Hg 7.5, MCV 67.4, platelet 268,000, Microcytic and Hypochromic, Anisocytosis, Elliptocytes, Target cells


TTS balloon dilatation: 12 mm for 1 minute and 15 mm for 1 minute


Ectopic sebaceous gland in the esophagus

[¾Öµ¶ÀÚ Áú¹®] ½Äµµ¿¡¼­µµ sebaceous gland°¡ ³ª¿Ã ¼ö ÀÖ½À´Ï±î?

[ÀÌÁØÇàÀÇ ´äº¯] Reference¸¦ ±×´ë·Î ¿Å±â´Â °ÍÀÌ ³ªÀ» °Í °°½À´Ï´Ù. Âü°íÇϽñ⠹ٶø´Ï´Ù.

Sebaceous glands generally arise in close association with hair follicles to form the pilosebaceous apparatus, but they are also found independently. Ectopic sebaceous glands have been reported arising at a variety of sites, including oral cavatiy, genitals, eye and orbits, nipples, palms and soles, parotid glands, and esophagus. Ectopic sebaceous glands in the esophagus are recognized as one or more small maculas in the esophageal mucosa and resemble gastric xanthomas. (Hoshika. Dig Dis Sci 1995;40:387-290)

½ÄµµÇÇÁö¼±Àº »óÇÇÇÏÀÇ Á¡¸·°íÀ¯Ãþ¿¡ Á¸ÀçÇÏ°í ÀÖ°í Á¡¸·°íÀ¯ÃþÀÇ ¼±¹æ(àÍÛ®)°ú ½Äµµ³»°­À¸·ÎÀÇ ¿ÜºÐºñµµ°üÀ¸·Î ÀÌ·ç¾îÁ®ÀÖ´Ù. µû¶ó¼­ À°¾È¼Ò°ßÀº ÀÛÀº Ȳ¹é»öÁ¶ÀÇ ÆíÆòÀ¶±â¶óµçÁö °ú¸³»óÀÇ ¿äöÀ» ¼ö¹ÝÇÏ´Â ²ÉÀÙ¸ð¾ç À¶±â µîÀ¸·Î °üÂûµÇ´Â ¼±¹æºÎºÐ°ú, Á߽ɺγª Á¤»ó¿¡ ¹é»öÀÇ ÀÛÀº µ¹±â°¡ º¸ÀÌ´Â µµ°üºÎºÐÀ¸·Î ±¸¼ºµÇ¾î ÀÖ´Ù. À§ xanthoma¿Í À¯»çÇÑ È²»öÁ¶ÀÇ À¶±â¼º º´º¯À¸·Î °üÂûµÇ´Âµ¥, µµ°üºÎºÐÀÎ Áß½ÉÀÇ ÀÛÀº ¿øÇüÀÇ È²»öÁ¡À̶óµç°¡ ÀÛÀº À¶±â°¡ º¸À̸é ÇÇÁö¼±(sebaceous gland)À¸·Î Áø´ÜÇÒ ¼ö ÀÖ´Ù. (Monna. À§¿Í Àå. 2008;43:263-273)


Asymptomatic esophageal candidiasis

[2013-7-11. S º´¿ø chief resident Áú¹®] ÃÖ±Ù ½Äµµ¿¡¼­ ÀÚÀßÇÑ whitish plaque °°Àº º´º¯À» º¸¾Ò½À´Ï´Ù. ¹°·Î Àß ¾Ä°ÜÁöÁö ¾Ê°í, acanthosis º¸´Ù´Â ¸í¹éÈ÷ whitish ÇÏ¿© Candida°¡ ÀǽɵǴ º´º¯À̾ú½À´Ï´Ù.


Áõ·Ê 1: M/49, underlying disease (-), Sx : non-specific


Áõ·Ê 2: F/61, ´ç´¢º´, previous candida Hx (+)

2¹ø ȯÀÚºÐÀº Á¶Á÷°Ë»ç·Î Candida·Î Áø´ÜÀÌ µÇ¾ú½À´Ï´Ù. Áú¹®Àº Á¶Á÷°Ë»ç°¡ negative ÀÎ 1¹ø ȯÀÚ¿¡¼­ Candida¶ó°í ºÒ·¯µµ ÁÁÀ»Áö¿ä? ³»½Ã°æ »çÁø¸¸ ºÁ¼­´Â ºñ½ÁÇØ º¸ÀÔ´Ï´Ù. Áõ»óÀÌ Æ¯ÀÌÀûÀÌÁö ¾Ê°í underlying disease°¡ ¾ø°í Àǽɸ¸µÇÁö Á¶Á÷°Ë»ç·Î È®ÀεÇÁö ¾Ê´Â »ç¶÷µé¿¡¼­ Candida¿¡ ÁØÇØ Ä¡·á°¡ ÇÊ¿äÇÒÁö ¹®Àǵ帳´Ï´Ù.


[2013-7-17. ÀÌÁØÇà ´äº¯]

1. ½Äµµ CandidaÁõÀÇ Á¶Á÷°Ë»çÀÇ sensitivity´Â ±×¸® ³ôÁö ¾Ê½À´Ï´Ù. ƯÈ÷ ¹«Áõ»ó ¼ºÀÎÀÌ°í Áõ»óÀÌ ½ÉÇÏÁö ¾ÊÀº ȯÀÚ¿¡¼­´Â ´õ¿í ³·½À´Ï´Ù. µû¶ó¼­ Á¶Á÷°Ë»ç¿¡¼­ ³ª¿À¸é Candida ½Äµµ¿°À¸·Î È®ÁøÇÒ ¼ö ÀÖÁö¸¸ ³ª¿ÀÁö ¾Ê¾Ò´Ù°í ¾Æ´Ï¶ó°í ¸»ÇÒ ¼ö ¾ø½À´Ï´Ù.

2. µÎ¹ø° Áõ·Êó·³ ¹«Áõ»óÀÌ°í °æÇÑ Candida ½Äµµ¿°À» ²À Ä¡·áÇØ¾ß ÇÏ´ÂÁö ¸íÈ®ÇÏÁö ¾Ê½À´Ï´Ù. Ä¡·áÇÏÁö ¾Ê¾Æµµ ÁÁ´Ù´Â ÁÖÀåµµ ¸¹½À´Ï´Ù. Àúµµ Ä¡·áÇÏÁö ¾Ê¾Æµµ µÈ´Ù°í »ý°¢ÇÕ´Ï´Ù. ±×·¯³ª Çö½ÇÀûÀ¸·Î Á¶Á÷°Ë»ç·Î È®ÀαîÁö µÇ¾ú´Âµ¥ Ä¡·áÇÏÁö ¾Ê¾Æµµ µÈ´Ù´Â °ÍÀ» ȯÀÚ¿¡°Ô ¼³µæÇϱⰡ ½±Áö ¾Ê½À´Ï´Ù. ±×·¡¼­ ±×³É fluconazole 1ÁÖÀÏ Åõ¾àÇÏ°ï ÇÕ´Ï´Ù. Á¦ ½º½º·Î »ý°¢°ú ÇൿÀÌ ´Ù¸£±â ¶§¹®¿¡ ´Ã °í¹ÎÇÕ´Ï´Ù. ÁÁÀº ¿¬±¸ ÁÖÁ¦°¡ ¾Æ´Ò ¼ö ¾ø½À´Ï´Ù. ´©±º°¡ ÁÁÀº ¿¬±¸·Î Á¦ °í¹ÎÀ» ÇØ°áÇØ Áֽñ⠹ٶø´Ï´Ù.

3. ù Áõ·Êó·³ ¹«Áõ»óÀÌ°í °æÇÑ Candida ½Äµµ¿°ÀÌ ÀǽɵǴµ¥ Á¶Á÷°Ë»ç·Î ³ª¿ÀÁö ¾Ê´Â °æ¿ì´Â Ä¡·áÇÏÁö ¾Ê½À´Ï´Ù. Á¶Á÷°Ë»ç·Î È®ÀÎµÈ °æ¿ì¶óµµ Ä¡·áÇÒÁö ¸»Áö¸¦ °í¹ÎÇÏ´Â »óȲ¿¡¼­, Á¶Á÷°Ë»ç¿¡¼­ ³ª¿ÀÁö ¾ÊÀº °Í±îÁö °í¹ÎÇÏ´Â °ÍÀº ÀÏÁ¾ÀÇ È£»ç¶ó°í »ý°¢ÇÕ´Ï´Ù. °£È¤ fluconazoleÀ» µå¸®°í ÃßÀû°üÂû¿¡¼­ Candida°¡ ¾ø¾îÁö´Â ¾ç»óÀ» º¸°í Áø´ÜÇÏ´Â ºÐµµ °è½ÃÁö¸¸, Àú´Â ±×·¸°Ô±îÁö ÇÒ ÇÊ¿ä´Â ¾ø´Ù°í »ý°¢ÇÕ´Ï´Ù.

4. ¸é¿ªÀÌ Á¤»óÀÎ »ç¶÷ÀÇ asymptomatic esophageal candidiasis¿¡ ´ëÇÑ ³í¹®Àº ã¾Æº¸Áú ¸øÇß½À´Ï´Ù. ±×·¯³ª AIDS ȯÀÚ¿¡¼­´Â Á¾Á¾ ³í¹®ÀÌ ÀÖ½À´Ï´Ù. Asymptomatic esophageal candidiasis¶óµµ ½ÉÇÏ´Ù°í »ý°¢µÇ¸é ¹Ýµå½Ã HIV antibody °Ë»ç¸¦ ÇØ¾ß ÇÑ´Ù´Â Á¡Àº ÀØÁö ¸¶½Ã±â ¹Ù¶ø´Ï´Ù.


[2013-7-17. S º´¿ø chief residentÀÇ °¨»çÀÇ ±Û] ±³¼ö´Ô. Áú¹®¿¡ ´ëÇÑ ´äº¯ °¨»çµå¸³´Ï´Ù. ^__^ ÀÌÈÄ¿¡µµ µÎºÐÀ̳ª ´õ Áø´ÜÀÌ µÇ¾ú½À´Ï´Ù. Á¦°¡ ±Ã±ÝÇؼ­ÀÎÁö ÀúÇÑÅ× ±×·± ȯÀںеéÀÌ À¯µ¶ ¸¹ÀÌ »ý±â´Â µí ÇÕ´Ï´Ù. »ç¼ÒÇÑ Áú¹®ÀÌ ÀÖÀ» ¶§ EndoToday ¸¦ ã¾Æº¸°ï Çϴµ¥ ½ÇÁ¦ ³»½Ã°æÀ» Çϸ鼭 »ý±â´Â ¾î·Á¿ò°ú ±Ã±ÝÁ¡µé¿¡ ´ëÇؼ­ detail ÇÏ°Ô Àß ¼³¸íÀÌ µÇ¾î ÀÖ¾î ¸¹Àº µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. »ç½Ç Àü°øÀÇ ¶§ºÎÅÍ °è¼Ó ±¸µ¶ÇÏ¿´Áö¸¸ ³»½Ã°æÀ» Á÷Á¢ Çغ¸¾Æ¾ß ±× °¡Ä¡¸¦ ¾Ë ¼ö ÀÖ´Â °Í °°½À´Ï´Ù. Ç×»ó ±³¼ö´ÔÀÇ ±³À°ÀûÀÎ ¿­Á¤¿¡ °¨»ç¸¦ µå¸®´Â ¹ÙÀÔ´Ï´Ù.


[2013³â 7¿ù 7ÀÏ Á¦ 20ȸ ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ºÎ¿ï°æÁöȸ ¼¼¹Ì³ª]


»õº® 8½Ã breakfast meeting Àå¸é

¿¹³â°ú ´Þ¸® ¾Æħ 8½Ã¿¡ Breakfast meeting (Meet the professor. How to start ESD for gastric neoplasm)À» ÅëÇÏ¿© ESD¸¦ óÀ½ ½ÃµµÇÏ°íÀÚ ÇÏ´Â ºÐµéÀ» À§ÇÑ ½Ã°£ÀÌ ÀÖ¾ú½À´Ï´Ù. ¸Å¿ì È°¹ßÇÑ discussionÀÌ ÀÖ¾ú½À´Ï´Ù. ºÎÁÂÀåÀ̴̼ø Á¶ÁÖ¿µ ¼±»ý´Ô²²¼­´Â "(1) ¾î·Á¿î ºÎÀ§ºÎÅÍ ¸ÕÀúÇ϶ó, (2) Áß·ÂÀ» »ý°¢Ç϶ó"´Â µÎ °¡Áö Á¡À» °­Á¶Çϼ̽À´Ï´Ù. ±×¸®°í delayed perforationÀ» À¯ÀÇÇÏ°í ȯÀÚ¿¡°Ô »çÀü¿¡ Àß ¼³¸íÇ϶ó, lower body anterior wallÀº inner circular musculeÀÌ ¾ø¾î¼­ õ°øÀ§ÇèÀÌ ³ôÀ¸´Ï ÁÖÀÇÇ϶ó´Â µîÀÇ Áß¿äÇÑ comment¸¦ Áּ̽À´Ï´Ù. Àú´Â ÃʽÉÀÚ¸¦ À§ÇÏ¿© ¾Æ·¡¿Í °°Àº comment¸¦ Çß½À´Ï´Ù.

"ESD´Â ±â±¸µµ ¹ßÀüÇÏ¿´°í, Ã¥ÀÚµµ ¸¹°í, seminar³ª live demonstration Âü¼®±âȸµµ ¿­·ÁÀÖÀ¸¹Ç·Î ´©±¸³ª ÇÒ ¼ö ÀÖ´Â ½¬¿î ½Ã¼úÀÌ µÇ¾ú½À´Ï´Ù. ±×·¯³ª 100¹øÀº ÇØ¾ß ½¬¿öÁý´Ï´Ù. ±×º¸´Ù Àü(îñ)ÀÌ ¹®Á¦ÀÔ´Ï´Ù.

¼­¿ïÀÇ 3Â÷ ÀÇ·á±â°ü¿¡¼­ ÀÏÇÏ´Â Àú·Î¼­´Â ESD°¡ °¥¼ö·Ï Èûµé¾îÁüÀ» ´À³§´Ï´Ù. ½±°í ÀÛÀº º´¼Ò´Â Áö¹æÀ̳ª 2Â÷º´¿ø¿¡¼­ ´Ù Ä¡·áÇÏ°í ÀÖÀ¸¹Ç·Î ¾î·Á¿î º´¼Ò¸¸ selectionµÇ¾î ÀǷڵǴ °Í ¾Æ´Ñ°¡ ½Í½À´Ï´Ù. ¿ì¸®³ª¶óÀÇ ESD ¼öÁØÀÌ ¸¹ÀÌ ³ô¾ÆÁ³±â ¶§¹®¿¡ ´Ùµé Àß ÇÏ°í °è½Ã¸®¶ó°í ¹Ï½À´Ï´Ù. ±×·¯³ª °£È¤ À§Ä¡°¡ ÆòÀÌÇÏ°í ±î´Ù·Î¿î ¸ð¾çÀÌ ¾Æ´Ñµ¥µµ ¾îó±¸´Ï ¾ø´Â ÇüÆí¾ø´Â ½Ã¼ú ÈÄ lateral margin involvement ȤÀº local recurrence·Î ÀǷڵǴ ȯÀÚµµ ÀÖ½À´Ï´Ù. ÂüÀ¸·Î ¾ÈŸ±î¿î ÀÏÀÔ´Ï´Ù.

Àú´Â ¿©·¯ºÐ¿¡°Ô ù ¸î ¹øÀÇ ½Ã¼ú¿¡ ÁÖÀÇÇ϶ó°í ¸»¾¸µå¸®°í ½Í½À´Ï´Ù. Àû¾îµµ 10-20¹ø Á¤µµ´Â °æÇ踹Àº ±³¼ö(ȤÀº °í¼ö)µéÀÇ ½Ã¼úÀ» completeÇÏ°Ô observation ÇϽñ⠹ٶø´Ï´Ù. ±Ùó ´ëÇк´¿øÀ» ¹æ¹®ÇÏ½Ã¸é µË´Ï´Ù. Àü°øÀÇ ½ÃÀý¿¡ º» °ÍÀº ¼Ò¿ëÀÌ ¾ø½À´Ï´Ù. ±¸°æ²ÛÀÌ ¾Æ´Ï¶ó °ß½À»ýÀÇ Åµµ·Î, ³»°¡ Á÷Á¢ ½ÃµµÇغ¸°Ú´Ù´Â ¸¶À½À¸·Î observationÀ» Çϸé Àü°øÀÇ ¶§¿¡´Â º¼ ¼ö ¾ø¾ú´ø ¸¹Àº °ÍÀÌ º¸ÀÏ °ÍÀÔ´Ï´Ù.

¸¶Áö¸· ºÎŹÀÔ´Ï´Ù. Á¦¹ß ÄÚÄ¡¸¦ ¹Þ¾Æ°¡¸é¼­ ¹è¿ì½Ã±â ¹Ù¶ø´Ï´Ù. ÀÚ½ÅÀÇ Ã¹ ESD ½Ã¼ú ¶§ °æÇ踹Àº ¼±¹è¸¦ ³»½Ã°æ½Ç·Î ¸ð¼Å¼­ µÚ¿¡¼­ ºÁ ´Þ¶ó°í ºÎŹµå¸®½Ê½Ã¿ä. ±×³¯ Àú³á ¸ÚÁø ½Ä»ç(ȤÀº ¼ú)¸¦ ´ëÁ¢ÇÏ½Ã¸é µË´Ï´Ù. Àý´ë È¥ÀÚ ½ÃÀÛÇÏÁö ¸¶½Ê½Ã¿ä. ±×¸®°í ÀÚ½ÅÀÌ Çß´ø ½Ã¼ú Àå¸é »çÁøÀ» e-mail·Î º¸³»¼­ comment¸¦ ¹ÞÀ¸½Ê½Ã¿ä. ±Ý¹æ ½Ç·ÂÀÌ ´Ã °ÍÀÔ´Ï´Ù."


¿©·¯ ±³¼ö´ÔµéÀÌ ÁÁÀº °­ÀǸ¦ ÇØ Áּ̽À´Ï´Ù. ±× Áß 'À§ÀÇ °Å´ë ÁÖ¸§'¿¡ ´ëÇÏ¿© °­ÀÇÇϽŠ±è±¤ÇÏ ±³¼ö´ÔÀÇ °á·Ð slide¸¦ ¼Ò°³ÇÕ´Ï´Ù. ¸ô·¡ ÇÑ Àå Âï¾ú½À´Ï´Ù.


À±¿µÈÆ ±³¼ö´Ô²²¼­ ESD¿¡ ´ëÇÏ¿© °­ÀÇÇÑ ³»¿ë Áß "³»ÃøÁ¾ÁÖ»çÇà±Ù (medial longitudinal oblique muscle) ºÐÆ÷ºÎÀ§ Ư¡ÀÇ ÀÌÇØ" ºÎºÐÀÇ °­ÀÇ ÀڷḦ ¾à°£ ÁÙ¿©¼­ ¿Å±é´Ï´Ù (¼¼¹Ì³ª Ã¥ÀÚ 15-16 ÆäÀÌÁö)

"... ÀüÁ¤ºÎ º´º¯ ESD¿¡ Àͼ÷ÇØÁ³´õ¶óµµ, ¸·»ó üºÎ º´º¯ÀÇ ESD¸¦ Á¢ÇÏ¸é ³­À̵µ°¡ ±Þ°ÝÈ÷ ³ô¾ÆÁüÀ» ´À³¢´Â °æ¿ì°¡ ¸¹´Ù. À̸¦ ±Øº¹Çϱâ À§Çؼ­´Â À§ÀÇ Çغα¸Á¶Àû Ư¼º, ƯÈ÷ ³»ÃøÁ¾ÁÖ»çÇà±ÙÀÇ ºÐÆ÷ Ư¡À» ¾Ë¾Æ¾ß ÇÑ´Ù.

ÀüÁ¤ºÎ´Â Á¡¸·ÇÏÃþ ºÐÆ÷ Ç÷°üÀÌ °¡´Ã°í ºóµµ°¡ ÀûÀ¸¸ç, Áú±ä ¼¶À¯°¡ Àû±â ¶§¹®¿¡ ´ëü·Î ¹Ú¸®°¡ ¿ëÀÌÇÏ´Ù. ¹Ý¸é, üºÎ´Â Á¡¸·ÇÏÃþ¿¡ Áú±ä ¼¶À¯°¡ ¸¹°í, Ç÷°üÀÌ ±½°í ¸¹±â ¶§¹®¿¡ Á¡¸·ÇÏÃþ ¹Ú¸®°¡ ¾î·Æ´Ù. Á¡¸·ÇÏÃþÀÇ ¼º»óÀº À§Ã¼ºÎ Àüº®°ú À§Ã¼ºÎ Èĺ®¿¡¼­ °¡Àå Å« Â÷À̸¦ º¸ÀδÙ. ÀÌ ºÎÀ§´Â ³»ÃøÁ¾ÁÖ»çÇà±Ù(medial longitudinal oblique muscle)ÀÇ ºÐÆ÷ºÎÀ§°ú ÀÏÄ¡ÇÑ´Ù. ³»ÃøÁ¾ÁÖ»çÇà±ÙÀº À§ ºÐ¹®ºÎºÎÅÍ Ã¼ºÎ Àüº®°ú Èĺ®À» Ç×ÇÏ¿© ÁÖÇàÇÏ°í ÀϺΰ¡ üºÎ ´ë¸¸±îÁö ºÐÆ÷ÇÏ´Â ºÒ¿ÏÀüÇÑ ±ÙÀ°ÀÌ´Ù. ³»ÃøÁ¾ÁÖ»çÇà±ÙÀÇ ±Ù¼¶À¯ »çÀÌ·Î ±½Àº perforating vesselµéÀÌ ºÐÁöÇÏ¿© Á¡¸·ÇÏÃþ³»¿¡ ±½Àº Ç÷°üÀÇ ±×¹°¸ÁÀ» Çü¼ºÇϴµ¥, À̸¦ ȾÁÖÇ÷°ü¸Á(transverse vasoganglion)À̶ó°í ºÎ¸¥´Ù. ÀÌ Ç÷°ü¸ÁÀÇ ÁÖÀ§¿¡´Â Áú±ä ¼¶À¯È­°¡ µ¿¹ÝµÇ¾î ÀÖ¾î ÀÏ°øÀÇ ±Ù¸·(fasciae)°ú °°Àº ÃþÀ» Çü¼ºÇÑ´Ù. µû¶ó¼­ À§Ã¼ºÎ Àüº®, Èĺ®, ´ë¸¸ º´º¯ÀÇ ¹Ú¸®´Â ¸Å¿ì ¾î·Æ´Ù.

±×·¯³ª ÀÌ·¯ÇÑ ºÎÀ§¿¡¼­µµ ÃâÇ÷À» ÃÖ¼ÒÈ­ÇÏ°í ½±°Ô ¹Ú¸®ÇÒ ¼ö ÀÖ´Â ¹æ¹ýÀÌ ÀÖ´Ù. ȾÁÖÇ÷°ü¸ÁÀÇ ¾Æ·¡ÂÊÀ¸·Î ±íÀº Á¡¸·ÇÏÃþ, Áï ±ÙÃþ°ú Á¡¸·ÇÏÃþÀÇ °æ°èºÎÀ§¿¡´Â ÀüÁ¤ºÎ Á¡¸·ÇÏÃþ°ú ºñ½ÁÇÏ°Ô Ç÷°üÀÌ Àû°í ¼¶À¯°¡ ÀûÀº ÃþÀÌ Á¸ÀçÇÑ´Ù. ÀÌ ¹Ú¸®½Éµµ(±íÀº Á¡¸·ÇÏÃþ)¸¦ À¯ÁöÇϸ鼭 ¹Ú¸®¸¦ ÁøÇàÇÏ´Ù °£È¤ ¸¸³ª´Â ±ÙÀ°À» ¶Õ°í ³ª¿À´Â ±½Àº perforating vesselÀº ÁöÇ÷°âÀÚ¸¦ »ç¿ëÇÏ¿© ²Ä²ÄÈ÷ precoagulationÀ» ÇØ ÁØ´Ù.

°¡Àå ¾î·Á¿î Á¡Àº ÀûÀýÇÑ ¹Ú¸®½Éµµ¿¡ µµ´ÞÇϱâ À§ÇØ È¾ÁÖÇ÷°ü¸ÁÀ» Åë°úÇÏ´Â µ¿¾È¿¡ ¹ß»ýÇÏ´Â ÃâÇ÷¿¡ ´ëÇÑ ´ëóÀÌ´Ù. À̶§´Â forced coagulation ¶Ç´Â Swift coagulation ¸ðµå¸¦ »ç¿ëÇÏ¿© knife¸¦ ÀüÈÄ·Î À̵¿½ÃÅ°¸é¼­ ȾÁÖÇ÷°ü¸Á°ú Áú±ä ¼¶À¯°¡ È¥ÀçµÈ Ç¥ÃþÀÇ Á¡¸·ÇÏÃþÀ» ±¤¹üÀ§ÇÏ°Ô ÀÀ°í½ÃÅ°¸é¼­ ȾÁÖÇ÷°ü¸Á ¾Æ·¡Ãþ±îÁö Åë°úÇÏ´Â 'ÀÀ°í¸ðµå trimming'À̶ó´Â Á¶ÀÛÀÌ µµ¿òÀÌ µÈ´Ù.


Àú´Â '»ý°Ë°á°ú ºñÁ¤Çü¼¼Æ÷ (atypia) ȤÀº ÀÌÇü¼º (dysplasia)ÀÇ Çؼ®'À̶ó´Â ±ä Á¦¸ñÀÇ °­ÀǸ¦ ÇÏ¿´½À´Ï´Ù. ±×°£ ¼±Á¾ (Àúµµ¼±Á¾°ú Ư¼öÇÑ »óȲ¿¡¼­ÀÇ °íµµ¼±Á¾)¿¡ ´ëÇÏ¿© APC ½Ã¼úÀ» ÇÏ¿´´ø °á°úµµ ÀϺΠ¼Ò°³ÇÏ¿´½À´Ï´Ù. ¾Æ·¡ ±×¸²À» Ŭ¸¯ÇÏ½Ã¸é °­ÀÇÀڷḦ º¸½Ç ¼ö ÀÖ½À´Ï´Ù.


(Powerpoint PDF, 2.9 M)

[Home]